- Home
- RRC vs TECH Comparison
RRC vs TECH Comparison
Compare RRC & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRC
- TECH
- Stock Information
- Founded
- RRC 1976
- TECH 1976
- Country
- RRC United States
- TECH United States
- Employees
- RRC N/A
- TECH N/A
- Industry
- RRC Oil & Gas Production
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RRC Energy
- TECH Health Care
- Exchange
- RRC Nasdaq
- TECH Nasdaq
- Market Cap
- RRC 8.0B
- TECH 7.9B
- IPO Year
- RRC N/A
- TECH 1989
- Fundamental
- Price
- RRC $37.86
- TECH $49.94
- Analyst Decision
- RRC Hold
- TECH Buy
- Analyst Count
- RRC 18
- TECH 9
- Target Price
- RRC $42.00
- TECH $73.88
- AVG Volume (30 Days)
- RRC 2.9M
- TECH 2.1M
- Earning Date
- RRC 04-22-2025
- TECH 05-07-2025
- Dividend Yield
- RRC 0.95%
- TECH 0.64%
- EPS Growth
- RRC N/A
- TECH N/A
- EPS
- RRC 1.11
- TECH 0.83
- Revenue
- RRC $2,610,836,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- RRC $34.77
- TECH $8.19
- Revenue Next Year
- RRC $8.93
- TECH $8.61
- P/E Ratio
- RRC $32.97
- TECH $60.22
- Revenue Growth
- RRC 12.00
- TECH 4.72
- 52 Week Low
- RRC $27.29
- TECH $46.44
- 52 Week High
- RRC $41.95
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- RRC 62.18
- TECH 44.19
- Support Level
- RRC $33.42
- TECH $46.77
- Resistance Level
- RRC $35.31
- TECH $50.81
- Average True Range (ATR)
- RRC 1.06
- TECH 2.02
- MACD
- RRC 0.51
- TECH 0.41
- Stochastic Oscillator
- RRC 99.01
- TECH 46.82
About RRC Range Resources Corporation
Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.18 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.